The global pharmaceutical industry faces unprecedented challenges. For a business whose success is closely linked to new drug discovery, the continuing decline in R&D productivity is not the best news. With the reducing supply of blockbuster drugs, patented therapies, an irreversible conservatism in the global business climate setting in, and mature markets plateauing, pharmaceutical companies are being impelled to redefine their business strategy and models.
As the industry searches for new avenues for growth, its attention is being drawn to emerging markets. Unlike developed markets which are relatively homogenous and well understood, emerging markets exhibit varied characteristics and call for unconventional approaches to sales and marketing, as well as a sound grasp of the behavior of the local healthcare ecosystem.
Mobile, cloud, geographical information system (GIS) along with analytics, can be used to counter the challenges faced by pharma players. These high impact technologies can help in accessing the last mile sales data, users’ information and track competitors’ movement in highly granular ways with ease.
Specifically, Pharma companies need to embark upon challenges like:
Mobile, cloud, geographical information system (GIS) along with analytics, can be used to counter the challenges faced by pharma players. These high impact technologies can help in accessing the last mile sales data, users’ information and track competitors’ movement in highly granular ways with ease.
Most of the leading pharmaceutical companies across the globe are partnering with us, because:
Intellilink’s solutions, which address the above important challenges, can be a game changer for the pharma industry.
© 2021 Intellilink Technologies. all rights reserved.
Developed by Intellilink Technologies.